Our Services
Medical Information
Helpful Resources
Published on: 4/24/2026
Mounjaro can lead to diarrhea in roughly 10 to 20 percent of users by speeding intestinal transit, boosting fluid secretion, and shifting gut bacteria, though most cases are mild and improve with simple measures. Dietary tweaks, hydration, timing doses, and over-the-counter remedies often control symptoms, though persistent or severe diarrhea may require reconsidering therapy.
There are several factors to weigh when deciding whether to switch medications, so see below for critical details to guide your next steps.
Mounjaro (tirzepatide) is a dual GLP-1/GIP receptor agonist approved for type 2 diabetes and chronic weight management. While it offers significant benefits—better blood sugar control, weight loss, and cardiovascular improvements—a common side effect is gastrointestinal upset, including diarrhea. Understanding why does Mounjaro cause diarrhea, how to manage it, and when to consider changing therapy can help you stay on track without undue discomfort.
Several overlapping mechanisms explain Mounjaro-related diarrhea:
Enhanced Gastrointestinal Motility
Fluid and Electrolyte Secretion
Altered Bile Acid Metabolism
Microbiome Shifts
Clinical trial data (e.g., the SURPASS program) show diarrhea in roughly 10–20% of Mounjaro users. Key points:
Before deciding to switch medications, try these first-line strategies:
Mounjaro's benefits often outweigh its side effects, but in some cases changing therapy makes sense:
If any of these apply, discuss alternatives with your healthcare provider. Options may include:
Mounjaro has transformed diabetes and weight‐loss management for many people:
Diarrhea is unpleasant but often temporary and manageable. Careful dose titration, dietary adjustments, and simple OTC remedies frequently keep symptoms under control. When diarrhea persists or seriously impacts daily life, it's reasonable to explore alternative treatments.
Your healthcare provider can help you weigh Mounjaro's powerful benefits against its gastrointestinal side effects. Together, you can optimize a treatment plan that improves your health and fits your lifestyle—diarrhea doesn't have to be a deal-breaker. Remember, never make changes to your medication without professional guidance.
(References)
* Karagiannidis E, Papazoglou D, Giannakeas G, Ntoskas E, Skepastianos P, Tsinopoulos C, Koukoulis G. Adverse Events Associated with Tirzepatide in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis. Diabetes Ther. 2023 Feb;14(2):1505-1516. doi: 10.1007/s13300-023-01377-5. Epub 2023 Feb 3. PMID: 36737592; PMCID: PMC9931754.
* Frias JP, Davies MJ, Rosenstock J, Saxon B, Thoutu E, Alberro R, Roy A, Liu B, Cui J, Pétavy F, Haupt A, Bergman BK, Dawed AY, Brown K, Dotson S, Gammon E, Ahmad A, Tang W, Li T, Konrardy-Wilson V. Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. N Engl J Med. 2021 Aug 5;385(6):503-515. doi: 10.1056/NEJMoa2107519. Epub 2021 Jun 25. PMID: 34170882.
* Jastreboff AM, Aronne LJ, Ahmad NN, Wharton L, Collazo-Clavell MG, Wadden TA, Hanley L, Walsh R, Auerbach P, Zelle K, John S, Portron V, Nauck M, Haupt A, Rubino DM. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022 Jul 21;387(3):205-216. doi: 10.1056/NEJMoa2206038. Epub 2022 Jun 4. PMID: 35714047.
* Wilding JPH, Batterham RL, Blickwede M, Nauck MA, Brown K, Ahmad A, Dotson S, Tang W, Jodar E. Tirzepatide for the treatment of obesity: A review. Diabetes Obes Metab. 2023 Feb;25 Suppl 1:10-18. doi: 10.1111/dom.14917. Epub 2023 Jan 20. PMID: 36717578; PMCID: PMC10091873.
* Thomas SM, Vella A, Alsaad H, Tella SH, Alsaad H, Abusada H, Siddiqui AD, Shah NP, Hamouda M, Ahmad F, Alsaad H, Thomas RM. Gastrointestinal adverse events of GLP-1 receptor agonists and GIP/GLP-1 receptor agonists: a systematic review and meta-analysis. Pharmacol Res Perspect. 2023 Feb;11(2):e01090. doi: 10.1002/prp2.1090. Epub 2023 Feb 22. PMID: 36823906; PMCID: PMC9946461.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.